Status:
UNKNOWN
Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.
Lead Sponsor:
Dong-A ST Co., Ltd.
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
19+ years
Brief Summary
Multi-center, open, non-intervention and observational study to Evaluate the efficacy and safety of Suganon tab. or Sugamet XR tab. in patients with Type 2 diabetes
Eligibility Criteria
Inclusion
- The subject is aged ≥19 years
- The subject has type 2 diabetes mellitus
Exclusion
- 1\. The subject has a contraindication
Key Trial Info
Start Date :
March 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2021
Estimated Enrollment :
1971 Patients enrolled
Trial Details
Trial ID
NCT04326166
Start Date
March 25 2020
End Date
July 31 2021
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanggye paik pospital
Seoul, Nowon-gu, South Korea, 01757